Ann: Change of Director's Interest Notice - Rennie, page-35

Spot on Mozz. Building conviction in a biotech takes many hours of reading, researching, pondering, calculating and questioning. I can find people with negative views on PAR and RENNIE, but they simply haven’t done the work to build the conviction in the drug and the way it is advancing and performing, guided by Rennie and co. If you aren’t prepared to do the work, you just have to trust the others that have, or move on. Some vocal skeptics I have had the opportunity to speak to (brokers and other professionals) elect not to lift the lid and have a look what’s inside. Time poor? Burnt by past failures, lazy? Outside of circle of competence??